About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Femoral Bone Metastases | Clinical Trials | Clareo Health

Back to clinical trial search

Active Not RecruitingNANCT01428895

Femoral Bone Metastases

Bone is a common site of metastasis for a range of malignancies. Bone metastases have the potential to cause significant morbidity including pain, impairment of ambulation and reduced functional indep...

Lead sponsor: University Health Network, Toronto•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University Health Network, Toronto

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Histologically confirmed diagnosis of malignancy other than lymphoma
•Presence of femoral metastases at high risk of pathologic fracture (Mirels' score 8 or more)
•At least 18 years of age
•Able to provide written informed consent
•Able to participate in follow-up

Exclusion Criteria

•Surgical consultation for the purpose of obtaining a tissue/histological diagnosis only, not for treatment
•Histological diagnosis of lymphoma

Related studies

Patient Anxiety During Magnetic Resonance Imaging

NCT07671846 · Cancer

RECRUITINGPhase 3

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

NCT06274047 · Androgen Axis Suppression, Prostatectomy, and more

RECRUITINGPhase 3

Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)

NCT06079671 · Locally Advanced Cervical Cancer

Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates

NCT06689488 · Lung Cancer

Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India

NCT07209917 · Cervical Cancer, Human Papillomavirus (HPV) Infection, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 6, 2026Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhaseNA

Enrollment180

Start dateMar 2009

Last updatedMar 6, 2026

Condition

Cancer Metastatic Malignant Neoplasm to Femur Risk of Fracture

Locations shown

Mount Sinai Hospital

Toronto, Ontario

University Health Network, Princess Margaret Hospital

Toronto, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 6, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions